Tag: alzheimers

Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease

In Canada, lecanemab is indicated for the treatment of adult patients with…

GlobeNews Wire

Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock

October 15, 2025 17:15 ET  | Source: Annovis Bio Inc. MALVERN, Pa.,…

GlobeNews Wire

HKUST Scientists Reveal Critical Impacts of a Chinese Genetic Risk Factor in Alzheimer’s Disease

HONG KONG, Oct. 2, 2025 /PRNewswire/ -- A landmark study conducted by…

PRNW Agency

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China

September 28, 2025 19:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE,…

GlobeNews Wire

Where Empathy Meets Compassion: Championing Alzheimer’s Awareness

This World Alzheimer's Day, doctors, patients and their caregivers gathered for an…

PRNW Agency

C2N Announces Major Global Expansion, Adds Six New International Partners

PrecivityAD2â„¢ blood test now available in over seven additional countries with primary…

Business Wire

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: SNAP BENEFITS LINKED TO SLOWER COGNITIVE DECLINE, 10-YEAR STUDY FINDS

Key Takeaways Participating in the Supplemental Nutrition Assistance Program (SNAP) may help…

PRNW Agency